TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain

Immunological control of viral infections in the brain exerts immediate protection, and also long-term maintenance of brain integrity. Microglia are important for antiviral defense in the brain. Here, we report that herpes simplex virus type 1 (HSV1) infection of human induced pluripotent stem cell (hiPSC)-derived microglia down-regulates expression of genes in the TREM2 pathway. TREM2 was found to be important for virus-induced IFNB induction through the DNA-sensing cGAS-STING pathway in microglia, and for phagocytosis of HSV1-infected neurons. Consequently, TREM2 depletion increased susceptibility to HSV1 infection in human microglia-neuron co-cultures and in the mouse brain. TREM2 augmented STING signaling and activation of down-stream targets TBK1 and IRF3. Thus, TREM2 is important for the antiviral immune response in microglia. Since TREM2 loss-of-function mutations and HSV1 serological status are both linked to Alzheimer’s disease, this work poses the question whether genetic or virus-induced alterations of TREM2 activity predisposes to post-infection neurological pathologies. One Sentence Summary We identify TREM2 as an important component of the antiviral immune response in microglia, which is actively targeted by HSV1.

[1]  S. Paludan,et al.  Microglia Activate Early Antiviral Responses upon Herpes Simplex Virus 1 Entry into the Brain to Counteract Development of Encephalitis-Like Disease in Mice , 2022, Journal of virology.

[2]  L. Piccio,et al.  Soluble TREM2: Innocent bystander or active player in neurological diseases? , 2022, Neurobiology of Disease.

[3]  P. S. St George-Hyslop,et al.  Does Soluble TREM2 Protect Against Alzheimer's Disease? , 2022, Frontiers in Aging Neuroscience.

[4]  P. Kessler,et al.  STING-Mediated Interferon Induction by Herpes Simplex Virus 1 Requires the Protein Tyrosine Kinase Syk , 2021, mBio.

[5]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[6]  G. Gao,et al.  Critical role of Syk-dependent STAT1 activation in innate antiviral immunity. , 2021, Cell reports.

[7]  C. Cotman,et al.  Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease , 2020, Nature Communications.

[8]  J. Nyengaard,et al.  Brain immune cells undergo cGAS-STING-dependent apoptosis during herpes simplex virus type 1 infection. , 2020, The Journal of clinical investigation.

[9]  S. Rivest,et al.  An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis , 2020, Journal of Virology.

[10]  Li-Na Zhang,et al.  Independent and Correlated Role of Apolipoprotein E ɛ4 Genotype and Herpes Simplex Virus Type 1 in Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.

[11]  H. Rhinn,et al.  Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model , 2020, The Journal of experimental medicine.

[12]  H. Zetterberg,et al.  HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection , 2020, The Journal of experimental medicine.

[13]  M. Simons,et al.  Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region , 2020, EMBO molecular medicine.

[14]  G. Boivin,et al.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis , 2020, Clinical Microbiology Reviews.

[15]  R. Rizzo,et al.  HHV-6A infection induces amyloid-beta expression and activation of microglial cells , 2019, Alzheimer's Research & Therapy.

[16]  A. Mailles,et al.  Herpes simplex virus encephalitis update , 2019, Current opinion in infectious diseases.

[17]  Huaxi Xu,et al.  Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model , 2019, Nature Communications.

[18]  D. Holtzman,et al.  Loss of TREM2 function increases amyloid seeding but reduces plaque associated ApoE , 2018, Nature Neuroscience.

[19]  E. Masliah,et al.  Alterations in brain TREM2 and Amyloid‐β levels are associated with neurocognitive impairment in HIV‐infected persons on antiretroviral therapy , 2018, Journal of neurochemistry.

[20]  H. Neumann,et al.  Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis , 2018, Cell reports.

[21]  D. Holtzman,et al.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight , 2018, Nature Reviews Immunology.

[22]  Shuang Pan,et al.  Herpes Simplex Virus 1 γ134.5 Protein Inhibits STING Activation That Restricts Viral Replication , 2018, Journal of Virology.

[23]  J. Trojanowski,et al.  Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration , 2018, Alzheimer's & Dementia.

[24]  T. Hortobágyi,et al.  Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms , 2018, Acta Neuropathologica.

[25]  C. Zheng,et al.  Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity , 2018, Journal of Virology.

[26]  L. Piccio,et al.  The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity , 2018, Immunity.

[27]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[28]  D. Kober,et al.  TREM2-Ligand Interactions in Health and Disease. , 2017, Journal of molecular biology.

[29]  J. Nyengaard,et al.  Sensing of HSV-1 by the cGAS–STING pathway in microglia orchestrates antiviral defence in the CNS , 2016, Nature Communications.

[30]  L. Enquist,et al.  HSV‐1 ICP27 targets the TBK1‐activated STING signalsome to inhibit virus‐induced type I IFN expression , 2016, The EMBO journal.

[31]  D. Holtzman,et al.  TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.

[32]  D. Leib,et al.  Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1 , 2015, Journal of Virology.

[33]  T. Ørntoft,et al.  Functional IRF3 deficiency in a patient with herpes simplex encephalitis , 2015, The Journal of experimental medicine.

[34]  G. Eslick,et al.  Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis. , 2015, Journal of Alzheimer's disease : JAD.

[35]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[36]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[37]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[38]  D. Chaussabel,et al.  Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood , 2012, The Journal of experimental medicine.

[39]  W. Seaman,et al.  A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia , 2009, Journal of neurochemistry.

[40]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[41]  Z. Khachaturian Alzheimer's & Dementia: The Journal of the Alzheimer's Association , 2008, Alzheimer's & Dementia.

[42]  F. Schmidt Meta-Analysis , 2008 .

[43]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[44]  H. D. de Melker,et al.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe , 2004, Sexually Transmitted Infections.

[45]  L. Peltonen,et al.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.

[46]  Leena Peltonen,et al.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.

[47]  G. Wilcock,et al.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.

[48]  M. Hirsch,et al.  Acute viral encephalitis. , 1985, The Medical clinics of North America.

[49]  A. Frydén,et al.  ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS Randomised Multicentre Study in Consecutive Swedish Patients , 1984, The Lancet.